Vanda Jumps 21% After FDA Approves Motion Sickness Therapy
This article first appeared on GuruFocus. Vanda Pharmaceuticals (NASDAQ:VNDA) jumped roughly 21% in premarket trading after the U.S.…
Dow, S&P 500, Nasdaq futures rise as Fed rate cut bets surge after inflation data
CoreWeave (CRWV) was teed up to let down investors last night. And it did on several fronts. First,…